Burning Stock Analysis

BNR
 Stock
  

USD 2.46  0.14  5.38%   

The latest fall in stock price could raise concerns from retail investors as the firm is trading at a share price of 2.46 on 459,802 in volume. The company executives have failed to build on market volatilities in September. However, diversifying your overall positions with Burning Rock Biotech may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.17. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Burning Rock partners.
Continue to Trending Equities.
  
The Burning Rock stock analysis report makes it easy to digest most publicly released information about Burning Rock and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Burning Stock analysis module also helps to analyze the Burning Rock price relationship with some important fundamental indicators such as market cap and management efficiency.

Burning Stock Analysis Notes

About 50.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.12. Some equities with similar Price to Book (P/B) outperform the market in the long run. Burning Rock Biotech recorded a loss per share of 1.06. The entity had not issued any dividends in recent years. The firm had a split on the 1st of August 2014. Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the Peoples Republic of China. The company was incorporated in 2014 and is headquartered in Guangzhou, China. Burning Rock operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1394 people. For more info on Burning Rock Biotech please contact Victor Lawrick at 86 20 3403 7871 or go to https://www.brbiotech.com.

Burning Rock Biotech Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Burning Rock's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Burning Rock Biotech or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Burning Rock Biotech generated a negative expected return over the last 90 days
Burning Rock Biotech has high historical volatility and very poor performance
Burning Rock Biotech has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 536.76 M. Reported Net Loss for the year was (886.67 M) with profit before taxes, overhead, and interest of 364.15 M.
Burning Rock Biotech has about 1.33 B in cash with (509.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from itbusinessnet.com: Burning Rock Announces Results of 2022 Annual General Meeting - IT Business Net

Burning Rock Biotech Upcoming and Recent Events

Earnings reports are used by Burning Rock to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Burning Rock previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report9th of March 2022
Next Financial Report24th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End9th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Burning Rock SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Burning Rock prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Burning Rock investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Burning Rock Biotech specific information freely available to individual and institutional investors to make a timely investment decision.

Burning Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Burning Rock is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Burning Rock Biotech backward and forwards among themselves. Burning Rock's institutional investor refers to the entity that pools money to purchase Burning Rock's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Massachusetts Financial Services CoCommon Shares4.4 M12.8 M
Kynam Capital Management LpCommon Shares4.3 M12.5 M
Vanguard Group IncCommon Shares1.7 M4.8 M
Blackrock IncCommon Shares1.6 M4.7 M
Ark Investment Management LlcCommon Shares1.8 M4.3 M
Orbimed Advisors LlcCommon Shares1.4 MM
Renaissance Technologies LlcCommon Shares1.1 M3.2 M
Note, although Burning Rock's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Burning Market Capitalization

The company currently falls under 'Small-Cap' category with total capitalization of 249.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Burning Rock's market, we take the total number of its shares issued and multiply it by Burning Rock's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Burning Profitablity

Burning Rock's profitability indicators refer to fundamental financial ratios that showcase Burning Rock's ability to generate income relative to its revenue or operating costs. If, let's say, Burning Rock is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Burning Rock's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Burning Rock's profitability requires more research than a typical breakdown of Burning Rock's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (165.19) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (165.45) %, which entails that for every $100 of revenue, it lost -1.65.

Management Efficiency

The entity has Return on Asset of (23.17) % which means that on every $100 spent on asset, it lost $23.17. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (44.46) %, meaning that it generated no profit with money invested by stockholders. Burning Rock management efficiency ratios could be used to measure how well burning rock biotech manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 6th of October, Burning Rock shows the risk adjusted performance of 0.0066, and Mean Deviation of 4.65. Burning Rock Biotech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for Burning Rock Biotech, which can be compared to its rivals. Please confirm Burning Rock Biotech standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if Burning Rock Biotech is priced correctly, providing market reflects its regular price of 2.46 per share. Please also double-check Burning Rock Biotech total risk alpha, which is currently at 0.1721 to validate the company can sustain itself at a future point.

Burning Rock Biotech Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Double Exponential Moving Average indicator was developed by Patrick Mulloy. It consists of a single exponential moving average and a double exponential moving average. This indicator is more responsive to Burning Rock Biotech changes than the simple moving average.
.

Burning Rock Predictive Daily Indicators

Burning Rock intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Burning Rock stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Burning Rock Forecast Models

Burning Rock time-series forecasting models is one of many Burning Rock's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Burning Rock's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Burning Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Burning Rock prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Burning shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Burning Rock. By using and applying Burning Stock analysis, traders can create a robust methodology for identifying Burning entry and exit points for their positions.
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the Peoples Republic of China. The company was incorporated in 2014 and is headquartered in Guangzhou, China. Burning Rock operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1394 people.

Current Burning Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Burning analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Burning analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
24.85Strong Buy2Odds
Burning Rock Biotech current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Burning analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Burning stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Burning Rock Biotech, talking to its executives and customers, or listening to Burning conference calls.
Burning Analyst Advice Details

Burning Stock Analysis Indicators

Burning Rock Biotech stock analysis indicators help investors evaluate how Burning Rock stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Burning Rock shares will generate the highest return on investment. By understating and applying Burning Rock stock analysis, traders can identify Burning Rock position entry and exit signals to maximize returns.
Quick Ratio3.69
Fifty Two Week Low1.7400
Revenue Growth27.10%
Shares Short Prior Month382.28k
Average Daily Volume Last 10 Day307.17k
Average Daily Volume In Three Month511.17k
Shares Percent Shares Out0.86%
Gross Margins69.82%
Forward Price Earnings-3.79
Float Shares45.22M
Fifty Two Week High17.6650
Enterprise Value To Ebitda1.09
Fifty Day Average3.2228
Two Hundred Day Average5.7255
Enterprise Value To Revenue-1.71
Continue to Trending Equities. You can also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for analysis

When running Burning Rock Biotech price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Is Burning Rock's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Burning Rock. If investors know Burning will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Burning Rock listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Burning Rock Biotech is measured differently than its book value, which is the value of Burning that is recorded on the company's balance sheet. Investors also form their own opinion of Burning Rock's value that differs from its market value or its book value, called intrinsic value, which is Burning Rock's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Burning Rock's market value can be influenced by many factors that don't directly affect Burning Rock's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Burning Rock's value and its price as these two are different measures arrived at by different means. Investors typically determine Burning Rock value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Burning Rock's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.